Reasons to be testing: Transitioning complex cancer genomics into routine oncology practice

9 December 2020

In this presentation, Dr. Philip Beer, Head of Genomic Strategy at the Glasgow Precision Oncology Laboratory, University of Glasgow, discusses the rationale for providing comprehensive genomic profiling for all cancer patients as part of routine clinical care. Dr. Beer outlines why and how testing should be delivered, examines the impact on individual cancer patients, and explains how deploying complex genomic analysis offers the potential to enable a self-learning healthcare system.